UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.072

Sortiert nach

Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly

The journal of clinical endocrinology and metabolism, 2014-10, Vol.99 (10), p.3644-3652

2014

Link zum Volltext

Verfügbarkeit prüfen

Insulin-Like Growth Factor (IGF) I, -II, and IGF Binding Protein-3 and Risk of Ischemic Stroke

The journal of clinical endocrinology and metabolism, 2005-11, Vol.90 (11), p.5937-5941

2005

Link zum Volltext

Verfügbarkeit prüfen

Sustained AS160 and TBC1D1 phosphorylations in human skeletal muscle 30 min after a single bout of exercise

Journal of applied physiology (1985), 2014-08, Vol.117 (3), p.289-296

2014

Link zum Volltext

Verfügbarkeit prüfen

Growth Hormone (GH)-Induced Insulin Resistance Is Rapidly Reversible: An Experimental Study in GH-Deficient Adults

The journal of clinical endocrinology and metabolism, 2011-08, Vol.96 (8), p.2548-2557

2011

Link zum Volltext

Verfügbarkeit prüfen

Growth hormone-induced insulin resistance in human subjects involves reduced pyruvate dehydrogenase activity

Acta Physiologica, 2014-02, Vol.210 (2), p.392-402

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of GH substitution on exercise capacity and muscle strength in GH-deficient adults: a meta-analysis of blinded, placebo-controlled trials

Clinical endocrinology (Oxford), 2009-12, Vol.71 (6), p.860-866

2009

Link zum Volltext

Verfügbarkeit prüfen

Time-course effects of physiological free fatty acid surges on insulin sensitivity in humans

Acta Physiologica, 2011-03, Vol.201 (3), p.349-356

2011

Link zum Volltext

Verfügbarkeit prüfen

Insulin resistance after a 72-h fast is associated with impaired AS160 phosphorylation and accumulation of lipid and glycogen in human skeletal muscle

American journal of physiology: endocrinology and metabolism, 2012-01, Vol.302 (2), p.E190-E200

2012

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer risk in hyperprolactinemia: a population-based cohort study and meta-analysis of the literature

European journal of endocrinology, 2015-08, Vol.173 (2), p.269

2015

Link zum Volltext

Verfügbarkeit prüfen

Dose-response effects of free fatty acids on amino acid metabolism and ureagenesis

Acta Physiologica, 2008-03, Vol.192 (3), p.369-379

2008

Link zum Volltext

Verfügbarkeit prüfen

The Ghrelin Response to Exercise before and after Growth Hormone Administration

The journal of clinical endocrinology and metabolism, 2007-01, Vol.92 (1), p.297-303

2007

Link zum Volltext

Verfügbarkeit prüfen

Testing for growth hormone deficiency in adults − how to respond?

Clinical endocrinology (Oxford), 2003-01, Vol.58 (1), p.18-19

2003

Link zum Volltext

Verfügbarkeit prüfen

Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3

European journal of endocrinology, 2015-11, Vol.173 (5), p.553

2015

Link zum Volltext

Verfügbarkeit prüfen

Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure

Journal of internal medicine, 2006-07, Vol.260 (1), p.11-21

2006

Link zum Volltext

Verfügbarkeit prüfen

Anabolic effects of oral leucine-rich protein with and without β-hydroxybutyrate on muscle protein metabolism in a novel clinical model of systemic inflammation—a randomized crossover trial

The American journal of clinical nutrition, 2021-09, Vol.114 (3), p.1159-1172

2021

Link zum Volltext

Verfügbarkeit prüfen

Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo

Journal of endocrinological investigation, 2001-06, Vol.24 (6), p.430-437

2001

Link zum Volltext

Verfügbarkeit prüfen

Mortality in Cushing's syndrome: A systematic review and meta-analysis

European journal of internal medicine, 2012-04, Vol.23 (3), p.278-282

2012

Link zum Volltext

Verfügbarkeit prüfen

Should patients with adult GH deficiency receive GH replacement?

European journal of endocrinology, 2022-01, Vol.186 (1), p.D1

2022

Link zum Volltext

Verfügbarkeit prüfen

The Effect of 30 Months of Low-Dose Replacement Therapy with Recombinant Human Growth Hormone (rhGH) on Insulin and C-Peptide Kinetics, Insulin Secretion, Insulin Sensitivity, Glucose Effectiveness, and Body Composition in GH-Deficient Adults

The journal of clinical endocrinology and metabolism, 2000-11, Vol.85 (11), p.4173-4181

2000

Link zum Volltext

Verfügbarkeit prüfen

Incidence and late prognosis of Cushing's syndrome : A population-based study

The journal of clinical endocrinology and metabolism, 2001, Vol.86 (1), p.117-123

2001

Link zum Volltext

Verfügbarkeit prüfen

Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults

Clinical endocrinology (Oxford), 1994-11, Vol.41 (5), p.609-614

1994

Link zum Volltext

Verfügbarkeit prüfen

Circulating Levels of Ghrelin and GLP-1 are Inversely Related During Glucose Ingestion

Hormone and metabolic research, 2002-07, Vol.34 (7), p.411-413

2002

Link zum Volltext

Verfügbarkeit prüfen

What is the efficacy of switching to weekly pegvisomant in acromegaly patients well controlled on combination therapy?

European journal of endocrinology, 2016-05, Vol.174 (5), p.663

2016

Link zum Volltext

Verfügbarkeit prüfen

Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis

European journal of endocrinology, 2005-10, Vol.153 (4), p.545

2005

Link zum Volltext

Verfügbarkeit prüfen

Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study

European journal of endocrinology, 2015-09, Vol.173 (3), p.313

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.072

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(971)
Mit Volltextzugriff
(916)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(718)
Life Sciences & Biomedicine
(573)
Humans
(539)
Male
(341)
Female
(314)
Adult
(313)
Biological And Medical Sciences
(309)
Medical Sciences
(260)
Middle Aged
(202)
Endocrinology & Metabolism
(190)
Physical Sciences
(128)
Aged
(125)
Pharmacology. Drug Treatments
(98)
Adolescent
(91)
Medicin Och Hälsovetenskap
(90)
Animals
(76)
Fundamental And Applied Biological Sciences. Psychology
(74)
Double-Blind Method
(73)
Physics
(72)
Astronomy & Astrophysics
(71)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly

Insulin-Like Growth Factor (IGF) I, -II, and IGF Binding Protein-3 and Risk of Ischemic Stroke

Sustained AS160 and TBC1D1 phosphorylations in human skeletal muscle 30 min after a single bout of exercise

Growth Hormone (GH)-Induced Insulin Resistance Is Rapidly Reversible: An Experimental Study in GH-Deficient Adults

Growth hormone-induced insulin resistance in human subjects involves reduced pyruvate dehydrogenase activity

Impact of GH substitution on exercise capacity and muscle strength in GH-deficient adults: a meta-analysis of blinded, placebo-controlled trials

Time-course effects of physiological free fatty acid surges on insulin sensitivity in humans

Insulin resistance after a 72-h fast is associated with impaired AS160 phosphorylation and accumulation of lipid and glycogen in human skeletal muscle

Breast cancer risk in hyperprolactinemia: a population-based cohort study and meta-analysis of the literature

Dose-response effects of free fatty acids on amino acid metabolism and ureagenesis

The Ghrelin Response to Exercise before and after Growth Hormone Administration

Testing for growth hormone deficiency in adults − how to respond?

Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3

Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure

Anabolic effects of oral leucine-rich protein with and without β-hydroxybutyrate on muscle protein metabolism in a novel clinical model of systemic inflammation—a randomized crossover trial

Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo

Mortality in Cushing's syndrome: A systematic review and meta-analysis

Should patients with adult GH deficiency receive GH replacement?

The Effect of 30 Months of Low-Dose Replacement Therapy with Recombinant Human Growth Hormone (rhGH) on Insulin and C-Peptide Kinetics, Insulin Secretion, Insulin Sensitivity, Glucose Effectiveness, and Body Composition in GH-Deficient Adults

Incidence and late prognosis of Cushing's syndrome : A population-based study

Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults

Circulating Levels of Ghrelin and GLP-1 are Inversely Related During Glucose Ingestion

What is the efficacy of switching to weekly pegvisomant in acromegaly patients well controlled on combination therapy?

Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis

Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study

Suchergebnisse filtern